Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,512.98
(
0.53%
)
US TECH 100
29,122.60
(
1.47%
)
Dow Jones
50,485.73
(
-0.19%
)
Brent Oil
97.14
(
-3.99%
)
Bitcoin
76,438.22
(
-1.08%
)
News Focus
News Focus
Post# of 257629
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123011
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 186326

Thursday, 09/17/2015 5:22:26 PM

Thursday, September 17, 2015 5:22:26 PM

Post# of 257629
FDA approves Vraylar* for schizophrenia and bipolar disorder:

http://finance.yahoo.com/news/allergan-gedeon-richter-plc-receive-183000040.html

Forest labs licensed this drug from Hungary’s Gideon Richter many years ago. The FDA issued a CRL on the first review cycle in 2013 (#msg-94290786).

*a/k/a cariprazine.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today